August 23, 2018
When public health emergencies threaten developing nations, governments may look for cheap, fast ways to secure necessary medicine. One option is compulsory licensing, the topic of a new “Fast Facts” from the Global Alliance for Patient Access.
July 24, 2018
To import, or not to import? The question of whether to bring foreign, lower-priced versions of prescription drugs to the United States is back.
February 20, 2018
It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on these events and ensure that drugs are safe in everyday use?
December 5, 2017
Preventable drug safety issues caused nearly 200,000 deaths across the European Union in 2017. Now the European Medicines Agency is working to address that statistic by improving its drug track-and-trace system, known as EudraVigilance.
September 12, 2017
One in three U.S. drugs may have safety issues, explains a new Fast Facts policy brief from the Institute for Patient Access.
September 1, 2017
As many as one out of three drugs on the U.S. market may have safety issues, according to a recent…
May 16, 2017
One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals. And that statistic begs a crucial question: How can we really ensure patients’ safety in an age of sophisticated medications and accelerated approval processes?
January 16, 2017
The names of biologic and biosimilar medicines will include randomly generated four-letter suffixes, the Food and Drug Administration announced Thursday.
December 13, 2016
A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates across Europe.
October 20, 2016
This month’s World Health Organization Open Sessions with INN Stakeholders explored the value, and the future, of the biological qualifier system. The Global Alliance for Patient Access was pleased to present to WHO officials and an international group of fellow stakeholders.
